Unknown

Dataset Information

0

Geriatric assessment and survival among older adults receiving postremission therapy for acute myeloid leukemia.

ABSTRACT:

SUBMITTER: Saad M 

PROVIDER: S-EPMC7735162 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Geriatric assessment and survival among older adults receiving postremission therapy for acute myeloid leukemia.

Saad Mohammed M   Loh Kah Poh KP   Tooze Janet A JA   Pardee Timothy S TS   Ellis Leslie R LR   Powell Bayard L BL   Bhave Rupali Roy RR   Geiger Ann M AM   Williamson Jeff D JD   Kritchevsky Stephen S   Klepin Heidi D HD  

Blood 20201201 23

Similar Datasets

Unknown Geriatric assessment for older adults receiving less-intensive therapy for acute myeloid leukemia: report of CALGB 361101.
| S-EPMC9631575 | biostudies-literature
Unknown Geriatric Assessment in Older Patients with Acute Myeloid Leukemia.
| S-EPMC6070943 | biostudies-literature
Unknown Personalizing therapy for older adults with acute myeloid leukemia: Role of geriatric assessment and genetic profiling.
| S-EPMC6481658 | biostudies-literature
Unknown Integrating geriatric assessment and genetic profiling to personalize therapy selection in older adults with acute myeloid leukemia.
| S-EPMC9482687 | biostudies-literature
Unknown Geriatric assessment in acute myeloid leukemia: current and future landscape.
| S-EPMC6156887 | biostudies-literature
Unknown Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia.
| S-EPMC6778500 | biostudies-literature
Unknown Persistent postremission clonal hematopoiesis shapes the relapse trajectories of acute myeloid leukemia.
| S-EPMC12008691 | biostudies-literature
Unknown Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice.
| S-EPMC10744855 | biostudies-literature
Unknown Treatment of Acute Myeloid Leukemia in Older Adults
| S-EPMC10670451 | biostudies-literature
Unknown Phase Ib trial of lenalidomide as post-remission therapy for older adults with acute myeloid leukemia: Safety and longitudinal assessment of geriatric functional domains.
| S-EPMC9326773 | biostudies-literature